Next Article in Journal
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Previous Article in Journal
Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model
Previous Article in Special Issue
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(9), 1180; https://doi.org/10.3390/pharmaceutics16091180
Action Date Notes Link
article pdf uploaded. 6 September 2024 16:49 CEST Version of Record https://www.mdpi.com/1999-4923/16/9/1180/pdf-vor
article supplementary file uploaded. 6 September 2024 16:49 CEST - https://www.mdpi.com/1999-4923/16/9/1180#supplementary
article pdf uploaded. 6 September 2024 16:57 CEST Updated version of record https://www.mdpi.com/1999-4923/16/9/1180/pdf-vor
article xml file uploaded 10 September 2024 10:32 CEST Original file -
article xml uploaded. 10 September 2024 10:32 CEST Update https://www.mdpi.com/1999-4923/16/9/1180/xml
article pdf uploaded. 10 September 2024 10:32 CEST Updated version of record https://www.mdpi.com/1999-4923/16/9/1180/pdf
article html file updated 10 September 2024 10:33 CEST Original file -
article supplementary file uploaded. 10 September 2024 10:52 CEST - https://www.mdpi.com/1999-4923/16/9/1180#supplementary
article html file updated 10 September 2024 10:54 CEST Update https://www.mdpi.com/1999-4923/16/9/1180/html
Back to TopTop